ENTITY

Crossject SA (ALCJ FP)

5
Analysis
Health CareFrance
Crossject SA develops needle-free injection systems for liquid medicines. The Company product ZENEO is tailored to deliver drugs intra-dermally, subcutaneously and intramuscularly.
more
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
x